FDA Cites Benefits of Merck HIV Drug
September 1st, 2007 By MATTHEW PERRONE, AP Business Writer(AP) -- A new HIV-fighting drug from Merck & Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
New HIV drugs on the way
Mar 01, 2007 |
4 / 5 (5) |
0
FDA approves antiretroviral drug
Aug 07, 2007 |
5 / 5 (1) |
0
Merck's heart failure drug misses trial goals
Jun 05, 2009 |
not rated yet |
1
New AIDS drug shows 'phenomenal' results
Jan 02, 2007 |
4.6 / 5 (91) |
0
FDA notes heart events, tumors with Novo drug
Mar 31, 2009 |
not rated yet |
0

